Genital Herpes Treatment Market to Hit $2.9 Billion by


Chicago, July 15 2022 (GLOBE NEWSWIRE) — According to the latest research report from Arizton, the global genital herpes treatment market is expected to grow at a CAGR of approximately 3.76%. About a third of MSM did not get an STI test between 2018 and 2020, while MSM with multiple sexual partners reported being tested less frequently in a cross-sectional US survey during the same period. Less monitoring and screening for STIs among MSM also increases the risk of spreading genital herpes as it may be asymptomatic or have unrecognized mild symptoms. Hence, increasing prevalence of genital herpes cases among the LGBTQ+ community will drive the demand for genital herpes treatment during the forecast period.

Scope of the Global Genital Herpes Treatment Market Report

Report attributes Details
MARKET SIZE (2027) $2.3 billion
MARKET SIZE (2021) $2.9 billion
CAGR (2022-2027) 3.76%
MARKET SEGMENTS Drug type, distribution channel, virus type, route of administration and region
GEOGRAPHICAL ANALYSIS North America, Europe, APAC, Latin America, Middle East and Africa
COUNTRIES COVERED GlaxoSmithKline, Glenmark Pharmaceuticals, Viatris, Novartis, Teva Pharmaceuticals and Bausch Health Companies

Click here to download the free sample report

Increase in demand for topical medications for the treatment of genital herpes

Acceptance of local/topical medications is high due to their benefits. The skin is ideal for the administration of drugs. Medical institutions and naturopaths are more frequently using online delivery systems for local or topical medications. This will provide an efficient and comfortable medical future for patients. Many other genital herpes medications are available in topical form and are also approved as over-the-counter medications. Patients can buy these drugs directly from pharmacies or online pharmacies.

The high penetration of the genital herpes treatments market in emerging economies will have a positive impact on the overall global market and contribute significantly to its growth over the forecast period. Favorable government initiatives, increase in healthcare expenditure and awareness of availability of wide range of genital herpes treatment for various patient groups will drive the growth of genital herpes treatment market in the emerging economies over the forecast period.


  • In 2021, North America was the major revenue contributor and accounted for 33.15% of the global genital herpes treatment market in 2021 during the forecast period.
  • The US genital herpes treatment market was estimated at $834.02 million in 2027, with North America accounting for the majority of the market with a share of 90.12%.
  • Acyclovir is the major contributor in the global genital herpes treatment market, and it is expected to witness an additional strong growth of $62.96 million during the forecast period.
  • Many leading companies with a wide range of genital herpes drugs have been acquired by major vendors to strengthen their market value and become a prominent player in the genital herpes treatment market.

The genital herpes treatment market is highly competitive and fragmented, even though the leaders are constantly consolidating their positions through strategic and high-profile mergers and acquisitions. Major vendors are acquiring leading companies offering drug formulations for the treatment of genital herpes to enhance their value and become top players. These vendors are implementing their R&D strategies to diversify their portfolios and expand their global presence. Novartis, GSK, Glenmark Pharmaceuticals, Viatris, Teva Pharmaceuticals and Bausch Health are key players in the global genital herpes treatment market. These key vendors add significant value to the market through their high R&D investments, diversified portfolios, and major strategic acquisitions.

Main suppliers

  • GlaxoSmithKline
  • Glenmark Pharmaceuticals
  • Viatris
  • Novartis
  • Teva Pharmaceuticals
  • Bausch healthcare companies

Other Important Suppliers

  • Reddy Laboratories
  • cipla
  • Pfizer
  • Eli Lilly & Company
  • Avet Pharmaceuticals
  • Aurobindo Pharmacy
  • centurion remedies
  • Abbott
  • Macleods Pharmaceuticals
  • CDF
  • Hetero
  • Zydus Group
  • Torrent Pharma
  • Pharmaceutical finecure
  • Medical remedies
  • Zeelab Pharmacy

Market segmentation
Type of drug

  • Aciclovir
  • Valacyclovir
  • Famciclovir
  • Other drugs

Distribution channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

type of virus

Route of administration:


  • North America
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
  • APAC
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • Latin America
  • Middle East and Africa
    • South Africa
    • Turkey
    • Saudi Arabia

Explore our life sciences profile to learn more about the industry.

Click here to download the free sample report

Read some of the best-selling reports:

About Arizton:

Arizton Advisory and Intelligence is an innovation and quality-driven company that provides industry-leading research solutions to clients around the world. We excel in providing comprehensive market intelligence reports and advisory and consultancy services.

We offer comprehensive market research reports on industries such as consumer goods and retail technology, automotive and mobility, smart technologies, healthcare and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers and trend forecasts.

Arizton has an exuberant and experienced team of analysts who are proficient in generating incisive reports. Our specialized analysts have exemplary skills in market research. We train our team in advanced research practices, techniques and ethics to surpass the production of impregnable research reports.

Click here to contact us
Call: +1-312-235-2040
+1 302 469 0707


About Author

Comments are closed.